|
|
||||||||




* Faculty of Agriculture, Yamaguchi University, Yoshida 1677-1, Yamaguchi 753-8515, Japan
Japan National Livestock Breeding Center, Anaguchi 72-21, Shimo-Kuriyagawa, Morioka 020-0123, Japan
Department of Animal Breeding and Reproduction, National Institute of Livestock and Grassland Sciences, Senbonmatsu 768, Nasushiobara, Tochigi 329-2793, Japan
1 Corresponding author: hiroya{at}yamaguchi-u.ac.jp
| ABSTRACT |
|---|
|
|
|---|
Key Words: blastocyst body condition score hyperinsulinemia superovulation
The protocol for multiple ovulation in Holstein yearling heifers and embryo transfer (MOET) is widely used for genetic improvement of dairy cattle; however, the use of superovulation remains affected by high variability in the ovulatory response to hormonal treatment and by a variable number of transferable embryos. Various factors, including lactation, breed, and repeated super-ovulation, have been associated with variability in the ovulatory response in adult cow donors, as reviewed previously (Kafi and McGowan, 1997). However, these factors cannot explain the variability in the ovulatory response of nonlactating Holstein yearling heifers, which have not previously been treated for multiple ovulations. Although nutrition affects the superovulatory response in beef heifers and ewes, in which the nutritional status was treated experimentally (Nolan et al., 1998; Yaakub et al., 1999; Lozano et al., 2003), the mechanisms through which it affects the superovulatory response have not been fully clarified. Under field conditions, it is not always possible to quantify the nutrient content of the feed supplied to donors, and it is also not always possible to measure the energy status and blood concentrations of various metabolites and metabolic hormones during a MOET program, although a recent report suggested the association of hyperinsulinemia with fewer follicles and compromised oocytes for fertilization and blastocyst formation in moderately fat and well-fed heifers (Adamiak et al., 2005). The BCS is the only possible method to assume the nutritional status of a donor easily without an additional cost. However, little is known about the relationship between BCS and the number of collected transferable embryos in Holstein donor heifers under field conditions. Therefore, we conducted a field survey to estimate the relationship between the number of collected transferable embryos and BCS on a 5-point scale, as well as blood concentrations of insulin and glucose, on the day of uterine flushing in Holstein donor heifers.
Holstein heifers used in this survey (n = 88, 13 mo old) were housed in a free-stall barn in the Iwate Station of the National Livestock Breeding Center, one of the largest farms utilizing the MOET program in Japan. Data were collected from donors superovulated between January 2005 and March 2007. They were provided TMR consisting largely of grass silage to meet the nutrient requirements according to the Japanese Feeding Standard (Agriculture, Forestry and Fisheries Research Council Secretariat, 1999). The feed volume per heifer per day was determined by the content of each lot of feed and by BW. The daily ration was divided between 2 feeding times: from 0900 to 0930 h, immediately after removal of the remaining feed, and from 1600 to 1630 h, utilizing stanchions to separate heifers to avoid social status preventing inferior heifers from having enough feed. However, because all heifers were allowed to eat the remaining feed at other times after being released from stanchions, the precise individual feed intake could not be measured in this survey study. Water and mineral blocks were provided ad libitum. Absence of diseases, including reproductive diseases, was confirmed by daily observation or by weekly rectal palpation with the aid of ultrasonography. All animals received human care according to law no. 105 and notification no. 6 and no. 22 of the Japanese Guidelines for Animal Care and Use.
Superovulatory treatment consisted of 8 i.m. injections during 4 d of decreasing doses of porcine FSH (Antrin-R, Kawasaki-Mitaka Pharmaceutical Co., Tokyo, Japan). The total FSH doses used were 24 armour units (5, 5, 4, 4, 2, 2, 1, and 1 armour units for each injection). The PGF2
analog (0.75 mg of cloprostenol, Estrumate, Sumitomo Chemical, Tokyo, Japan) was administered simultaneously with the seventh FSH injection. After confirming estrus, heifers were inseminated twice, about 48 and 60 h after the PGF2
injection, using frozen-thawed semen. Rectal palpation was prohibited in the period of superovulatory treatment in the MOET program, because stress induced by humans may decrease the ovarian response against porcine FSH, and pressure from rectal palpation on ovaries may increase the inappropriate timing of ovulation.
At 1330 h on d 7 (d 0 = day of AI), jugular blood was sampled and centrifuged at 12,000 x g for 20 min at 4°C, and plasma was harvested and stored at –35°C until analysis. At 1430 h on d 7, embryos were collected by nonsurgical uterine flushing using a balloon catheter (Fujihira Industry Co. Ltd., Tokyo, Japan), and lactate Ringer solution (Fuso Pharmaceutical Industries Ltd., Tokyo, Japan) supplemented with 1% fetal calf serum, 100 U/mL of penicillin G, and 0.1 mg/mL of streptomycin sulfate. The BCS of heifers was measured on a scale ranging from 1 (emaciated) to 5 (obese) with 0.25 spacing (Edmonson et al., 1989) on d 7. Rectal palpation with the aid of ultrasonography was performed to confirm the existence of corpus luteum after uterine flushing.
The recovered fluid was examined microscopically for quality grading of the recovered embryo according to the morphological criteria of quality and viability (Lindner and Wright, 1983; Callesen et al., 1995). Collected embryos were classified as excellent, good, fair, poor, degenerated, or unfertilized. The development stages of the embryo classified as excellent, good, fair, and poor were subclassified as morula, compact morula, blastocyst (including early blastocyst), or expanded blastocyst.
Plasma concentration of glucose was measured with an autoanalyzer (model-7170, Hitachi Co. Ltd., Tokyo, Japan) and commercial kit (Kainos Laboratories Inc., Tokyo, Japan). All samples were processed in a single assay with an intraassay coefficient of variation of less than 1.0% at 5.0 mM. Plasma insulin was assayed in duplicate with a commercial RIA kit (Insulin-Eiken, Eiken Chemical Co Ltd., Tokyo, Japan). All samples were processed in a single assay with a limit of detection of 10 pM and an intraassay coefficient of variation of 5.8% at 148 pM.
We calculated the sum of the number of excellent grade embryos and the number of good grade embryos (excellent/good grade embryos) for each heifer. The number of each grade of embryo, the number of excellent/good grade embryos, and the number of each stage of embryo in each heifer were subjected to square root transformation. Data were analyzed using Statview (version 5.0 for Macintosh, SAS Inst. Inc., Cary, NC). For the square root of embryo production data, significance of the effect of BCS was evaluated by ANOVA followed by Fishers protected LSD test. For plasma concentrations of glucose and insulin, significance of the effect of BCS was evaluated by ANOVA and Fishers protected LSD test. Null hypothesis was rejected if the P-value was less than or equal to 0.05 to show significant difference among the different BCS groups; however, we showed the detailed P-value when it was less than or equal to 0.10 for the detailed discussion. All results are presented as the means ± standard error of the means.
The number of heifers with a BCS score of 2.75, 3.00, 3.25, or 3.50 was 6, 35, 40, and 7, respectively. We assumed that most of the remaining feed of 2.75 BCS heifers had been consumed by 3.50 BCS heifers, because of the similar number of 2.75 BCS heifers and 3.50 BCS heifers. The 3.50 BCS heifers (449 ± 21 kg) were heavier (P < 0.05) than 2.75 (365 ± 23 kg), 3.00 (380 ± 10 kg), and 3.25 (403 ± 9 kg) BCS heifers, and 3.25 BCS heifers were heavier (P < 0.05) than 2.75 and 3.00 BCS heifers. However, there was no significant difference in metabolic BW among 2.75 (83.5 ± 10.5 kg), 3.00 (86.1 ± 5.6 kg), 3.25 (89.9 ± 5.2 kg), or 3.50 (97.5 ± 9.8 kg) BCS heifers. The 2.75, 3.00, 3.25, or 3.50 BCS heifers produced 15.0 ± 4.1 (range from 3 to 27), 15.6 ± 1.6 (0 to 36), 11.3 ± 1.5 (0 to 35), and 10.0 ± 2.7 (2 to 20) embryos, respectively. All heifers responded to superovulation treatment; however, no embryo was collected from one 3.00 BCS heifer and one 3.25 BCS heifer. There was no significant difference in almost all evaluated parameters (Figure 1a and 1b
), including the number of excellent/good grade embryos, among 2.75, 3.00, and 3.25 BCS heifers. However, 3.25 BCS heifers produced fewer (P < 0.05) embryos than 3.00 BCS heifers.
|
The 3.50 BCS heifers produced significantly more morula than 2.75, 3.00, or 3.25 BCS heifers (Figure 2a
), and 3.50 BCS heifers had a higher ratio of morula to the sum of excellent, good, fair, and poor embryos than 2.75, 3.00, or 3.25 BCS heifers, as shown in the concentric circle graph (Figure 2b
). In contrast, 2.75 BCS heifers tended to have more blastocysts than 3.25 (P = 0.06) and 3.50 (P < 0.05) BCS heifers (Figure 2a
).
|
We found a smaller number of excellent/good grade embryos in 3.50 BCS heifers than 3.00 or 3.25 BCS heifers. Possible reasons for such differences include the following: (1) disadvantage follicle recruitment (Gutierrez et al., 1997; Nolan et al., 1998); (2) compromised morphological and functional quality of oocytes for fertilization and development (Lozano et al., 2003; Freret et al., 2006); (3) change in ovarian steroidogenesis (Nolan et al., 1998; Armstrong et al., 2002); and (4) excess metabolic hormones and cytokines lead to suppressing embryo development.
Hyperinsulinemia is associated with fewer medium (4 to 8 mm)-sized follicles, the low maturation rate in vitro of oocytes collected by ultrasound-guided transvaginal follicular aspiration, and the low rate of blastocyst formation in moderately fat and well-fed heifers (Adamiak et al., 2005). The dietary-induced increase in insulin concentration seems to have a direct effect on steroidogenesis in follicles and follicle dynamics (Armstrong et al., 2002). Because 3.5 BCS heifers in the present study were hyperinsulinemic, this condition may be an important factor, if not all, in their compromised embryo production. Our data suggested the adverse effect of high BCS on development. However, we must be cautious in drawing a conclusion that high BCS affect the development only at the step from the morula to the blastocyst stage, although 3.50 BCS heifers produced significantly more morula than 2.75, 3.00, and 3.25 BCS heifers, and they produced fewer blastocysts than 2.75 BCS heifers. The embryos collected from high-BCS donors may be in slower development, and at an earlier stage of development on d 7, because of unknown mechanisms induced by high BCS. Further studies are required to clarify such mechanisms; however, one possible reason may be inappropriate signaling by maternally derived adipocytokines, for example, tumor necrosis factor-
(Daniel et al., 2003; Soto et al., 2003). The present study cannot provide evidence for these mechanisms, but it highlights the need to better understand the potentially interactive effects of higher BCS and hyperinsulinemia on embryo production also in field conditions.
About 8% of all heifers were BCS 3.50 in the present study, although we utilized stanchions in the free-stall barn to avoid social status preventing inferior heifers from having enough feed. A more strict and precise system to control the feed intake of each heifer based also on the BCS may be required to obtain maximum superovulation responses in Holstein yearling heifers for the MOET program for genetic improvement.
In conclusion, our results suggested no significant effect of BCS around 3.0 on embryo production, whereas 3.5 BCS heifers may have poorer embryo production.
Received for publication August 26, 2007. Accepted for publication December 5, 2007.
| REFERENCES |
|---|
|
|
|---|
(TNF), and CD14 in ovine adipose tissue and changes in circulating TNF in lean and fat sheep. J. Anim. Sci. 81:2590–2599.
on oocyte maturation and embryonic development in cattle. Am. J. Reprod. Immunol. 50:380–388.[Medline]This article has been cited by other articles:
![]() |
M A Velazquez, J Zaraza, A Oropeza, R Webb, and H Niemann The role of IGF1 in the in vivo production of bovine embryos from superovulated donors Reproduction, February 1, 2009; 137(2): 161 - 180. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |